- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biodesix Inc (BDSX)
Assess today's live Biodesix Inc (BDSX) share price, performance and insights using our live NASDAQ: BDSX stock exchange data.
Analyse the historical data and Biodesix Inc share price performance charts on this page. Our technical summary section provides analysis on Biodesix share price buy/sell indicators using real-time data (or discuss the Biodesix (BDSX) stock price today with other investors in the Biodesix NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ BDSX share price (ISIN: US09075X2071) to enhance your trading decisions with our free investment tools and resources.
What Is the Biodesix Inc Share Price Today?
The Biodesix share price today is 6.750.
What Is the Stock Symbol for Biodesix Inc
The stock symbol (or 'ticker') for Biodesix Inc is "BDSX."
What Stock Exchange Does Biodesix Inc Trade On?
Biodesix Inc is listed and trades on the NASDAQ stock exchange.
Is Biodesix Inc a Good Stock to Buy?
Determining whether Biodesix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Biodesix Inc share price performance charts on this page. Our technical summary section provides analysis on Biodesix share price buy/sell indicators using real-time data (or discuss the Biodesix (BDSX) stock price today with other investors in the Biodesix NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ BDSX share price (ISIN: US09075X2071) to enhance your trading decisions with our free investment tools and resources.
What Is the Biodesix Inc Share Price Today?
The Biodesix share price today is 6.750.
What Is the Stock Symbol for Biodesix Inc
The stock symbol (or 'ticker') for Biodesix Inc is "BDSX."
What Stock Exchange Does Biodesix Inc Trade On?
Biodesix Inc is listed and trades on the NASDAQ stock exchange.
Is Biodesix Inc a Good Stock to Buy?
Determining whether Biodesix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.645
7.032
52 wk Range
3.436
31.200
BDSX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.6457.032
52 wk Range
3.43631.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BDSX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
32.500
Upside
+381.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Biodesix Company Profile
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient’s immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development, and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Biodesix Inc Earnings Call Summary for Q1/2025
- Q1 2025 revenue up 21% YoY to $18M, driven by 18% growth in lung diagnostic testing and 61% in development services
- Stock declined 16.49% post-earnings to $0.30, as 2025 revenue guidance revised down to $80-85M
- Net loss improved 18% YoY to $11.1M; company targets adjusted EBITDA positivity by Q4 2025
- Gross margin improved to 79.4%; company plans to expand primary care sales team and explore MRD test commercialization
- CEO emphasized focus on revenue growth, operational effectiveness, and pipeline advancement amid market challenges
Last Updated: 13/05/2025, 22:50
Read Full TranscriptCompare BDSX to Peers and Sector
Metrics to compare | BDSX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBDSXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | 5.5x | −0.6x | |
PEG Ratio | −0.05 | −1.11 | 0.00 | |
Price/Book | −31.2x | 4.3x | 2.6x | |
Price / LTM Sales | 0.7x | 7.4x | 3.2x | |
Upside (Analyst Target) | - | 18.6% | 41.8% | |
Fair Value Upside | Unlock | −8.5% | 5.1% | Unlock |
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 32.500
(+381.48% Upside)
Earnings
Latest Release
Nov 03, 2025
EPS / Forecast
-1.16 / -0.06
Revenue / Forecast
21.80M / 20.83M
People Also Watch
FAQ
What Is the Biodesix (BDSX) Share Price Today?
The live Biodesix share price today is 6.750
What Stock Exchange Does Biodesix (BDSX) Trade On?
Biodesix is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Biodesix?
The stock symbol (also called a 'ticker') for Biodesix is "BDSX."
What Is the Current Biodesix Market Cap?
As of today, Biodesix market capitalisation is 53.66M.
What Is Biodesix's (BDSX) Earnings Per Share (TTM)?
The Biodesix EPS is currently -5.36 (Trailing Twelve Months).
When Is the Next Biodesix Earnings Date?
Biodesix's next earnings report will be released on 03 Nov 2025.
Is BDSX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Biodesix moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Biodesix Stock Split?
Biodesix has split 1 times. (See the BDSX stock split history page for full effective split date and price information.)
How Many Employees Does Biodesix Have?
Biodesix has 273 employees.
What is the current trading status of Biodesix (BDSX)?
As of 24 Dec 2025, Biodesix (BDSX) is trading at a price of 6.750, with a previous close of 6.810. The stock has fluctuated within a day range of 6.645 to 7.032, while its 52-week range spans from 3.436 to 31.200.
What Is Biodesix (BDSX) Price Target According to Analysts?
The average 12-month price target for Biodesix is USD32.5, with a high estimate of USD40 and a low estimate of USD20. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +381.48% Upside potential.
What Is the BDSX After Hours Price?
BDSX's last after hours stock price is 6.620, the stock has decreased by -0.130, or -1.930%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.